Hepatic dysfunction in sickle cell disease: A new system of classification based on global assessment

被引:48
作者
Berry, Philip A. [1 ]
Cross, Timothy J. S. [1 ]
Thein, Swee Lay [2 ]
Portmann, Bernard C. [1 ]
Wendon, Julia A. [1 ]
Karani, John B. [3 ]
Heneghan, Michael A. [1 ]
Bomford, Adrian [1 ]
机构
[1] Kings Coll Hosp London, Inst Liver Studies, London SE5 9RS, England
[2] Kings Coll Hosp London, Dept Haematol Med, London SE5 9RS, England
[3] Kings Coll Hosp London, Dept Radiol, London SE5 9RS, England
关键词
D O I
10.1016/j.cgh.2007.08.009
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Hepatic dysfunction in adults with sickle cell disease varies in character and severity from self-limited cholestasis to life-threatening acute liver failure and cirrhosis. Because previous attempts to describe patterns of liver disease have not reflected clinical experience, we aimed to characterize the presentation, clinicopathologic findings, and natural history of such patients. Methods: We reviewed the clinical, laboratory, radiographic, and histologic features with the natural history of 38 patients (mean age, 33 years) with Hb SS, SC, or S-beta thalassemia referred to a tertiary liver center for assessment. Results: Distinct disease patterns were identified that comprised massive hepatocellular necrosis (5%), acute severe sequestration and cholestasis in the context of sepsis (18%), cirrhosis (18%), chronic, fluctuating sequestration without cholestasis (21%), mechanical biliary obstruction (8%), siderosis without cirrhosis (8%), generalized cholangiopathy (8%), venous outflow obstruction (3%), and miscellaneous (11%). Of the 20 who required emergency admission, 8 did not survive their index admission, and 3 patients died during follow-up admissions (4 months-4 years later). There were 3 instances of hemorrhage related to liver biopsy. One patient underwent transplantation but died. Hematologic and biochemical markers did not discriminate well between survivors and nonsurvivors. The incidence of a second hepatic pathology (ie, viral hepatitis, autoimmune disease, transfusional siderosis) was 37% and was associated with the finding of more advanced histologic fibrosis. Conclusions: Patterns of hepatic dysfunction in sickle cell disease are diverse and demand clear characterization for each individual; however, groups with a poor prognosis can be identified after collation of clinical, laboratory, and radiologic data. Findings at biopsy (which is associated with higher risk of bleeding in this group) might be anticipated by noninvasive test results.
引用
收藏
页码:1469 / 1476
页数:8
相关论文
共 14 条
[1]
Ischaemic cholangiopathy and sickle cell disease [J].
Ahmed, M ;
Dick, M ;
Mieli-Vergani, G ;
Harrison, P ;
Karani, J ;
Dhawan, A .
EUROPEAN JOURNAL OF PEDIATRICS, 2006, 165 (02) :112-113
[2]
Sickle cell hepatopathy: Clinical presentation, treatment, and outcome in pediatric and adult patients [J].
Ahn, H ;
Li, CS ;
Wang, WF .
PEDIATRIC BLOOD & CANCER, 2005, 45 (02) :184-190
[3]
Sickle cell hepatopathy [J].
Banerjee, S ;
Owen, C ;
Chopra, S .
HEPATOLOGY, 2001, 33 (05) :1021-1028
[4]
THE LIVER IN SICKLE-CELL DISEASE - A CLINICOPATHOLOGIC STUDY OF 70 PATIENTS [J].
BAUER, TW ;
MOORE, GW ;
HUTCHINS, GM .
AMERICAN JOURNAL OF MEDICINE, 1980, 69 (06) :833-837
[5]
CHARLOTTE F, 1995, ARCH PATHOL LAB MED, V119, P46
[6]
Circumstances of death in adult sickle cell disease patients [J].
Darbari, Deepika S. ;
Kple-Faget, Paul ;
Kwagyan, John ;
Rana, Sohail ;
Gordeuk, Victor R. ;
Castro, Swaldo .
AMERICAN JOURNAL OF HEMATOLOGY, 2006, 81 (11) :858-863
[7]
Hillaire S, 2000, AM J GASTROENTEROL, V95, P300
[8]
LIVER INVOLVEMENT IN SICKLE-CELL DISEASE [J].
JOHNSON, CS ;
OMATA, M ;
TONG, MJ ;
SIMMONS, JF ;
WEINER, J ;
TATTER, D .
MEDICINE, 1985, 64 (05) :349-356
[9]
Kotila Taiwo, 2005, Ann Hepatol, V4, P261
[10]
MILLS LR, 1988, ARCH PATHOL LAB MED, V112, P290